Transgene S.A.

Transgene S.A. - Current Ratioverified

TRGNF

Price:

$0.85

Market Cap:

$108.44M

Transgene S.A. is a biotechnology company dedicated to the creation and advancement of therapeutic vaccines and oncolytic viruses. Its core mission is to develop innovative treatments for both cancer and various infectious diseases. The company's drug development pipeline includes several promising candidates: TG4050, a therapeutic vaccine, is currently in early-stage Phase I clinical trials for its potential use against ovarian cancer and certain types of HPV-negative head and neck cancers. TG4001, another therapeutic vaccine, has progressed to Phase II clinical trials, where it is being evaluated for the treatment of HPV-positive cancers. TG6002, an oncolytic virus, is undergoing Phase I/I...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

TRGNF

The Current Ratio as of June 2026 (TTM) for Transgene S.A. (TRGNF) is 9.62

According to Transgene S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 9.62. This represents a change of 191.32% compared to the average of 3.30 of the last 4 quarters.

Transgene S.A. (TRGNF) Historical Current Ratio (quarterly & annually)

How has TRGNF Current Ratio performed in the past?

The mean historical Current Ratio of Transgene S.A. over the last ten years is 3.44. The current 9.62 Current Ratio has changed 27.84% with respect to the historical average. Over the past ten years (40 quarters), TRGNF's Current Ratio was at its highest in in the June 2010 quarter at 13.64. The Current Ratio was at its lowest in in the June 2006 quarter at 0.

Quarterly (TTM)
Annual

Average

3.44

Median

3.07

Minimum

1.48

Maximum

9.62

Transgene S.A. (TRGNF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Transgene S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 550.92%

Maximum Annual Current Ratio = 9.62

Minimum Annual Increase = -56.27%

Minimum Annual Current Ratio = 1.48

Quarterly (TTM)
Annual
YearCurrent RatioChange
20259.62550.92%
20241.48-17.47%
20231.79-50.78%
20223.64-14.72%
20214.2789.49%
20202.25-15.42%
20192.6674.80%
20181.52-56.27%
20173.48-6.33%
20163.7294.71%

Transgene S.A. (TRGNF) Average Current Ratio

How has TRGNF Current Ratio performed in the past?

The current Current Ratio of Transgene S.A. (TRGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.30

5-year avg

4.16

10-year avg

3.44

Transgene S.A. (TRGNF) Current Ratio vs. Peers

How is TRGNF’s Current Ratio compared to its peers?

Transgene S.A.’s Current Ratio is greater than Hansa Biopharma AB (publ) (3.63), less than Silence Therapeutics plc (9.83), greater than Cellectis S.A. (1.52), greater than Immutep Limited (2.97), greater than Genfit S.A. (2.00), greater than hVIVO plc (1.63), greater than Santhera Pharmaceuticals Holding AG (1.29), greater than Mayne Pharma Group Limited (1.33), greater than Probi AB (publ) (6.94), greater than Oryzon Genomics S.A. (1.83),

Build a custom stock screener for Transgene S.A. (TRGNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Transgene S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Transgene S.A. (TRGNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Transgene S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Transgene S.A.'s Current Ratio?

How is the Current Ratio calculated for Transgene S.A. (TRGNF)?

What is the highest Current Ratio for Transgene S.A. (TRGNF)?

What is the 3-year average Current Ratio for Transgene S.A. (TRGNF)?

What is the 5-year average Current Ratio for Transgene S.A. (TRGNF)?

How does the current Current Ratio for Transgene S.A. (TRGNF) compare to its historical average?